An inactivated enterovirus 71 vaccine in healthy children

New England Journal of Medicine

Volumn 370, Issue 9, 2014, Pages 829-837

  Li, Rongcheng ^a   Liu, Longding ^b   Mo, Zhaojun ^a   Wang, Xuanyi ^c   Xia, Jielai ^d   Liang, Zhenglun ^e   Zhang, Ying ^b   Li, Yanping ^a   Mao, Qunying ^e   Wang, Jingjing ^b   Jiang, Li ^b   Dong, Chenghong ^b   Che, Yanchun ^b   Huang, Teng ^a   Jiang, Zhiwei ^d   Xie, Zhongping ^b   Wang, Lichun ^b   Liao, Yun ^b   Liang, Yan ^b   Nong, Yi ^a   Liu, Jiansheng ^b   Zhao, Hongling ^b   Na, Ruixiong ^b   Guo, Lei ^b   Pu, Jing ^b   Yang, Erxia ^b   Sun, Le ^b   Cui, Pingfang ^b   Shi, Haijing ^b   Wang, Junzhi ^e   Li, Qihan ^b   more..

^a Guangxi Autonomous Regional Center for Disease Control and Prevention   (China)

^b INSTITUTE OF MEDICAL BIOLOGY   (China)

^c FUDAN UNIVERSITY   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^e NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED ENTEROVIRUS 71 VACCINE; INACTIVATED VIRUS VACCINE; NEUTRALIZING ANTIBODY; PLACEBO; UNCLASSIFIED DRUG;

ALLERGY; ANOREXIA; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CHINA; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HAND FOOT AND MOUTH DISEASE; HUMAN; HUMAN EXPERIMENT; INFANT; INFECTION PREVENTION; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE REACTION; INJECTION SITE SWELLING; IRRITABILITY; MALE; NAUSEA; NORMAL HUMAN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SKIN REDNESS; TREATMENT OUTCOME; VOMITING; WEAKNESS;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHILD, PRESCHOOL; CHINA; DOUBLE-BLIND METHOD; ENTEROVIRUS A, HUMAN; FEMALE; FEVER; HAND, FOOT AND MOUTH DISEASE; HUMANS; INFANT; INJECTIONS, INTRAMUSCULAR; KAPLAN-MEIER ESTIMATE; MALE; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 84896713013     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1303224     Document Type: Article

References (18)

1. Modlin F. Coxsackieviruses, echoviruses, and newer enteroviruses. In: Mandell LG, Bennett EJ, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. Philadelphia: Churchill Livingstone, 2005:2148-61.
2. Hu M, Li Z, Wang J, et al. Determinants of the incidence of hand, foot and mouth disease in China using geographically weighted regression models. PLoS One 2012;7(6):e38978.
3. Ge-xin X, Yue-hua H, Shi-cheng Y, Jia-qi M. Epidemiology of hand, foot and mouth disease in children aged ≤5 years in China, 2008-2011. Ji Bing Jian Ce 2012;27:932-6. (In Chinese.)
4. Yi M, Yi T, Jian-jun M, Min-mei C, Fuyin B, Yi J. Epidemiological characteristics of hand foot and mouth disease in Guangxi province, 2010. Ji Bing Jian Ce 2011;26:611-3. (In Chinese.)
5. Jian-jun M, Yu J. Surveillance and analysis on hand foot and mouth disease in Guangxi Zhuang Autonomous Region in 2011. Occupation and Health 2012;28:2276-7. (In Chinese.)
6. Ho M, Chen E-R, Hsu K-H, et al. An epidemic of enterovirus 71 infection in Taiwan. N Engl J Med 1999;341:929-35. (Pubitemid 29441546)
7. Wang SM, Liu CC, Tseng HW, et al. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis 1999;29:184-90.
8. Huang XYKK, Kang K, Xu YL, et al. Etiology surveillance of hand-foot-mouth disease in Henan province between 2008 and 2011. Zhonghua Yu Fang Yi Xue Za Zhi 2012;46:883-7. (In Chinese.)
9. Tan X, Huang X, Zhu S, et al. The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008. PLoS One 2011;6(9):e25662.
10. Sun LM, Zheng HY, Zheng HZ, et al. An enterovirus 71 epidemic in Guangdong Province of China, 2008: epidemiological, clinical, and virogenic manifestations. Jpn J Infect Dis 2011;64:13-8.
11. Zhang Y, Zhu Z, Yang W, et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J 2010;7:94.
12. Zhang Y, Tan X, Cui A, et al. Complete genome analysis of the C4 subgenotype strains of enterovirus 71: predominant recombination C4 viruses persistently circulating in China for 14 years. PLoS One 2013;8(2):e56341.
13. De W, Changwen K, Wei L, et al. A large outbreak of hand, foot, and mouth disease caused by EV71 and CAV16 in Guangdong, China, 2009. Arch Virol 2011;156:945-53.
14. Liu L, Zhang Y, Wang J, et al. Study of the integrated immune response induced by an inactivated EV71 vaccine. PLoS One 2013;8(1):e54451.
15. Dong C, Liu L, Zhao H, et al. Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys. Vaccine 2011;29:6269-75.
16. Ma S-H, Liu J-S, Wang J-J, et al. Genetic analysis of the VP1 region of human enterovirus 71 strains isolated in Fuyang, China, during 2008. Virol Sin 2009;24:162-70.
17. Ma H, He F, Wan J, et al. Glucocorticoid and pyrazolone treatment of acute fever is a risk factor for critical and life-threatening human enterovirus 71 infection during an outbreak in China, 2008. Pediatr Infect Dis J 2010;29:524-9.
18. Liang Z, Mao Q, Gao Q, et al. Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines. Vaccine 2011;29:9668-74.